Sensus Healthcare, Inc. (FRA:5TX)
Germany · Delayed Price · Currency is EUR 3.500
+0.020 (0.57%)
At close: Nov 28, 2025
Sensus Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 35.61 | 41.81 | 24.41 | 44.53 | 27.04 | 9.58 | Upgrade | |
Revenue Growth (YoY) | -13.80% | 71.30% | -45.20% | 64.68% | 182.36% | -64.87% | Upgrade |
Cost of Revenue | 18.53 | 17.38 | 10.35 | 14.9 | 10.05 | 4.33 | Upgrade |
Gross Profit | 17.08 | 24.43 | 14.06 | 29.63 | 16.99 | 5.25 | Upgrade |
Selling, General & Admin | 15.05 | 12.13 | 10.76 | 11.34 | 9.43 | 9.33 | Upgrade |
Research & Development | 7.46 | 4.22 | 3.68 | 3.46 | 3.44 | 4.16 | Upgrade |
Operating Expenses | 22.51 | 16.34 | 14.44 | 14.8 | 12.87 | 13.48 | Upgrade |
Operating Income | -5.43 | 8.09 | -0.38 | 14.83 | 4.12 | -8.23 | Upgrade |
Interest Expense | - | - | - | - | -0 | -0.01 | Upgrade |
Interest & Investment Income | 0.76 | 0.93 | 0.99 | 0.38 | 0 | 0.07 | Upgrade |
EBT Excluding Unusual Items | -4.68 | 9.02 | 0.61 | 15.21 | 4.12 | -8.18 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 0.04 | 12.78 | -0 | - | Upgrade |
Other Unusual Items | - | - | - | - | - | 1.35 | Upgrade |
Pretax Income | -4.68 | 9.02 | 0.65 | 27.99 | 4.12 | -6.84 | Upgrade |
Income Tax Expense | -1.67 | 2.38 | 0.17 | 3.75 | - | - | Upgrade |
Net Income | -3.01 | 6.65 | 0.49 | 24.24 | 4.12 | -6.84 | Upgrade |
Net Income to Common | -3.01 | 6.65 | 0.49 | 24.24 | 4.12 | -6.84 | Upgrade |
Net Income Growth | - | 1270.51% | -98.00% | 488.59% | - | - | Upgrade |
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 | 16 | Upgrade |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 17 | 17 | 16 | Upgrade |
Shares Change (YoY) | 0.03% | 0.57% | -2.12% | 0.70% | 0.42% | 1.24% | Upgrade |
EPS (Basic) | -0.18 | 0.41 | 0.03 | 1.47 | 0.25 | -0.42 | Upgrade |
EPS (Diluted) | -0.18 | 0.41 | 0.03 | 1.46 | 0.25 | -0.42 | Upgrade |
EPS Growth | - | 1266.06% | -97.96% | 484.00% | - | - | Upgrade |
Free Cash Flow | 2.17 | -1.11 | -2.37 | -1.57 | -0.41 | -0.79 | Upgrade |
Free Cash Flow Per Share | 0.13 | -0.07 | -0.15 | -0.10 | -0.03 | -0.05 | Upgrade |
Gross Margin | 47.95% | 58.44% | 57.61% | 66.53% | 62.82% | 54.81% | Upgrade |
Operating Margin | -15.26% | 19.35% | -1.57% | 33.30% | 15.24% | -85.98% | Upgrade |
Profit Margin | -8.44% | 15.90% | 1.99% | 54.44% | 15.23% | -71.38% | Upgrade |
Free Cash Flow Margin | 6.09% | -2.65% | -9.73% | -3.53% | -1.53% | -8.28% | Upgrade |
EBITDA | -5.07 | 8.33 | -0.11 | 15.15 | 4.73 | -7.51 | Upgrade |
EBITDA Margin | -14.22% | 19.92% | -0.44% | 34.01% | 17.50% | -78.44% | Upgrade |
D&A For EBITDA | 0.37 | 0.24 | 0.28 | 0.32 | 0.61 | 0.72 | Upgrade |
EBIT | -5.43 | 8.09 | -0.38 | 14.83 | 4.12 | -8.23 | Upgrade |
EBIT Margin | -15.26% | 19.35% | -1.57% | 33.30% | 15.24% | -85.98% | Upgrade |
Effective Tax Rate | - | 26.32% | 25.61% | 13.38% | - | - | Upgrade |
Advertising Expenses | - | 1.2 | 1.2 | 0.9 | 0.46 | 0.52 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.